subject: CHEBI:26710


subject: UMLS:C4284513

subject_name: Cetuximab Ab

object_name: metastatic colorectal cancer

tested_intervention: unsure


subject: CHEBI:49603

subject_name: Lapatinib


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UMLS:C3539125

subject_name: other medicated shampoos in ATC


subject: UNII:820NH671E6

subject_name: Prexasertib

object_name: childhood neoplasm

tested_intervention: yes


subject: UNII:820NH671E6

object_name: neoplastic syndrome


subject: UNII:820NH671E6

object_name: cancer or benign tumor


subject: UNII:820NH671E6

object_name: neoplasm


subject: UMLS:C2745348

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C2745348

object_name: amyotrophic lateral sclerosis


subject: CHEBI:194135

subject_name: Ofloxacin

object_name: otitis media


subject: CHEBI:194135

object_name: infectious otitis media


subject: CHEBI:194135

object_name: Otitis Media, CTCAE


subject: UNII:O3571H3R8N

subject_name: Enobosarm

object_name: Muscle Atrophy


subject: UNII:O3571H3R8N

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:O3571H3R8N

object_name: obesity


subject: UNII:O3571H3R8N

object_name: Obesity, CTCAE


subject: CHEBI:52717

subject_name: Bortezomib

object_name: colorectal cancer


subject: CHEBI:52717

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL4297812

object_name: influenza A subtype H3N2 infection


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: Chronic prurigo


subject: CHEBI:92712

subject_name: ENDO-ATROPINE

object_name: lower urinary tract symptom


subject: CHEBI:91541


subject: UMLS:C1744162

subject_name: RPL 554

object_name: cystic fibrosis


subject: CHEBI:27375

subject_name: Vinblastine

object_name: Childhood Solid Neoplasm


subject: UMLS:C2985193

subject_name: Monofer

object_name: chronic kidney disease


subject: UMLS:C2985193

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C2985193

object_name: iron deficiency anemia


subject: UMLS:C3248676

subject_name: ONDANSETRON, ORAL, 4 MG (FOR CIRCUMSTANCES FALLING UNDER THE MEDICARE STATUTE, USE HCPCS Q CODE)

object_name: rectal carcinoma


subject: UMLS:C3248676

object_name: rectal cancer


subject: UMLS:C3248676

object_name: Childhood Rectal Carcinoma


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:60787

subject_name: TIMOLOL

object_name: diabetic macular edema


subject: CHEBI:39465

subject_name: timolol


subject: CHEBI:4702

subject_name: Dorzolamide


subject: CHEBI:404903

subject_name: Ertapenem

object_name: Colon Neoplasm


subject: CHEBI:404903

object_name: rectal neoplasm


subject: CHEBI:404903

object_name: Colonic diverticula


subject: PUBCHEM.COMPOUND:85364156

object_name: Gastrointestinal motility disorder


subject: UMLS:C3886758


subject: PUBCHEM.COMPOUND:75988815

subject_name: Elafibranor

object_name: kidney failure


subject: PUBCHEM.COMPOUND:75988815

object_name: kidney disorder


subject: UMLS:C5564077

subject_name: ROPEGINTERFERON

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C5227743

object_name: inherited lipid metabolism disorder


subject: UMLS:C5227743

object_name: Dyslipidemia


subject: UMLS:C4550206


subject: UMLS:C4550206


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: colorectal cancer


subject: UMLS:C0728976

object_name: colorectal carcinoma


subject: UMLS:C0728976

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: UNII:92E9B7675Y

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:92E9B7675Y

object_name: COPD, severe early onset


subject: UNII:82SK298EBU


subject: UNII:82SK298EBU


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Childhood Breast Carcinoma


subject: CHEBI:79699

object_name: breast carcinoma


subject: CHEBI:79699

object_name: breast cancer


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: melanoma


subject: CHEBI:22586

subject_name: antioxidant

object_name: Increased reactive oxygen species production


subject: UMLS:C0003402

subject_name: Antioxidants


subject: UMLS:C1699394

subject_name: Hylenex

object_name: cancer


subject: UMLS:C5854662

subject_name: PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector IMNN-001

object_name: fallopian tube carcinoma


subject: UMLS:C5854662

object_name: fallopian tube cancer


subject: UMLS:C5854662

object_name: primary peritoneal carcinoma


subject: UMLS:C5854662

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C5854662

object_name: peritoneal carcinoma


subject: UMLS:C5854662

object_name: ovarian cancer


subject: UMLS:C5854662

object_name: ovarian neoplasm


subject: UMLS:C5854662

object_name: ovarian carcinoma


subject: UMLS:C5854662

object_name: malignant epithelial tumor of ovary


subject: CHEBI:17026

subject_name: Progesterone

object_name: cervical intraepithelial neoplasia


subject: CHEBI:17026

object_name: dysplasia of cervix


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: CHEBI:63918

subject_name: Artesunate

object_name: cytomegalovirus infection


subject: UMLS:C5203933

subject_name: Personalized Neoepitope Yeast Vaccine YE-NEO-001

object_name: Childhood Breast Carcinoma


subject: UMLS:C5203933

object_name: breast carcinoma


subject: UMLS:C5203933

object_name: breast cancer


subject: UMLS:C5203933

object_name: liver cancer


subject: UMLS:C5203933

object_name: liver neoplasm


subject: UMLS:C5203933

object_name: Adult Liver Carcinoma


subject: UMLS:C5203933

object_name: liver carcinoma


subject: UMLS:C5203933

object_name: pancreatic neoplasm


subject: UMLS:C5203933

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5203933

object_name: malignant pancreatic neoplasm


subject: UMLS:C5203933

object_name: colorectal cancer


subject: UMLS:C5203933

object_name: colorectal carcinoma


subject: UMLS:C5203933

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5203933

object_name: non-small cell lung carcinoma


subject: UMLS:C5203933

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5203933

object_name: melanoma


subject: CHEBI:47458

subject_name: Saracatinib

object_name: ovarian cancer


subject: CHEBI:47458

object_name: ovarian neoplasm


subject: CHEBI:47458

object_name: ovarian carcinoma


subject: CHEBI:47458

object_name: primary peritoneal carcinoma


subject: CHEBI:47458

object_name: Primary Peritoneal Cancer


subject: CHEBI:47458

object_name: fallopian tube carcinoma


subject: CHEBI:47458

object_name: fallopian tube cancer


subject: UNII:WTT295HSY5

subject_name: Dulaglutide

object_name: cardiovascular disorder


subject: UMLS:C2976495


subject: CHEBI:36796

subject_name: duloxetine

object_name: migraine


subject: CHEBI:36796

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:94531

subject_name: belinostat

object_name: thymoma


subject: CHEBI:94531

object_name: thymus neoplasm


subject: CHEBI:94531

object_name: type C thymoma


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Transplant-Related Disorder


subject: UMLS:C5556327

subject_name: Anti-CD73 Monoclonal Antibody HLX23

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: Ulcerative Colitis Flare


subject: GTOPDB:11546

subject_name: aldafermin

object_name: Compensated cirrhosis


subject: GTOPDB:11546


subject: CHEMBL.COMPOUND:CHEMBL4298055

subject_name: ALDAFERMIN


subject: CHEMBL.COMPOUND:CHEMBL4298055


subject: UMLS:C5418311


subject: UMLS:C5418311


subject: CHEMBL.COMPOUND:CHEMBL1743009

subject_name: EFUNGUMAB

object_name: Cryptococcal meningitis


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Acne inversa


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C1449680

subject_name: Angiotensin II Type 1 Receptor Blockers

object_name: hypertension


subject: UMLS:C1449680

object_name: Hypertension, CTCAE


subject: UMLS:C1449680

object_name: myocardial infarction


subject: UMLS:C1449680

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C1449680

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C1449680

object_name: heart failure


subject: UMLS:C1449680

object_name: congestive heart failure


subject: UMLS:C1449680

object_name: arteriosclerosis disorder


subject: UMLS:C1449680

object_name: atherosclerosis


subject: UMLS:C0445115

subject_name: Normal saline

object_name: post operative nausea and vomiting


subject: CHEBI:60799

subject_name: Esketamine

object_name: Postoperative cognitive dysfunction


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: infertility


subject: CHEMBL.COMPOUND:CHEMBL4594355

object_name: Childhood Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594355

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594355

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594355

object_name: Microsatellite Instability


subject: CHEMBL.COMPOUND:CHEMBL4594355

object_name: cancer of unknown primary site


subject: CHEMBL.COMPOUND:CHEMBL4594355

object_name: mismatch repair cancer syndrome 1


subject: CHEMBL.COMPOUND:CHEMBL4594355

object_name: Turcot syndrome


subject: CHEMBL.COMPOUND:CHEMBL4594355

object_name: Mismatch Repair Deficiency


subject: UMLS:C4724859

subject_name: Geptanolimab


subject: UMLS:C4724859


subject: UMLS:C4724859


subject: UMLS:C4724859


subject: UMLS:C4724859


subject: UMLS:C4724859


subject: UMLS:C4724859


subject: UMLS:C4724859


subject: UNII:30Q3VS5HZ4


subject: UNII:30Q3VS5HZ4


subject: UNII:30Q3VS5HZ4


subject: UMLS:C3661318


subject: UMLS:C3661318


subject: UMLS:C3661318


subject: CHEBI:195181

subject_name: Alanylalanine

object_name: prostate carcinoma


subject: CHEBI:195181

object_name: prostate cancer


subject: CHEBI:15843

subject_name: Arachidonate


subject: CHEBI:15843


subject: UMLS:C0002520

subject_name: Amino Acids


subject: UMLS:C0002520


subject: PUBCHEM.COMPOUND:4479094

subject_name: Doxercalciferol


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:63717

object_name: HIV CNS INVOLVEMENT


subject: CHEBI:63625

subject_name: Tenofovir


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:73501

subject_name: Glu-Phe-Val

object_name: Acute HIV infection


subject: CHEBI:73501


subject: CHEBI:119486

subject_name: Efavirenz


subject: CHEBI:119486


subject: CHEBI:9434

subject_name: Telmisartan


subject: CHEBI:9434


subject: PUBCHEM.COMPOUND:9852982

subject_name: Ceftaroline

object_name: bacterial infectious disease


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: UNII:42EK42WHI5

subject_name: Lorecivivint

object_name: osteoarthritis, knee


subject: UMLS:C0141582

subject_name: saruplase

object_name: myocardial infarction


subject: UMLS:C0141582

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C0141582

object_name: Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:24795080

object_name: Alzheimer disease


subject: UMLS:C3886544


subject: GTOPDB:9195

subject_name: clazakizumab

object_name: Antibody-mediated rejection


subject: UNII:4S38Z8RA9O


subject: UMLS:C2830049


subject: UMLS:C4704930

subject_name: Neuronox

object_name: blepharospasm


subject: UNII:H1396W7D1H

subject_name: FAVEZELIMAB

object_name: bladder tumor


subject: UNII:H1396W7D1H

object_name: urinary bladder carcinoma


subject: UNII:H1396W7D1H

object_name: urinary bladder cancer


subject: UNII:H1396W7D1H

object_name: childhood bladder carcinoma


subject: UMLS:C4684393

subject_name: Favezelimab


subject: UMLS:C4684393


subject: UMLS:C4684393


subject: UMLS:C4684393


subject: UMLS:C3495568

object_name: HIV infection


subject: UMLS:C5235208

object_name: type 2 diabetes mellitus


subject: UMLS:C0939677

subject_name: Angiomax

object_name: cardiovascular disorder


subject: CHEBI:80343

subject_name: Mecasermin

object_name: Laron syndrome


subject: CHEBI:80343

object_name: growth hormone insensitivity syndrome


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Surgical procedure finding


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: grade III glioma


subject: UNII:9AG41L3AOQ

object_name: WHO Grade 4 Glioma


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:3844471

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:3844471

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0950968

subject_name: MGI 114


subject: UMLS:C0950968


subject: UMLS:C0950968


subject: CHEMBL.COMPOUND:CHEMBL5314366

subject_name: ESOMEPRAZOLE MAGNESIUM

object_name: Zollinger-Ellison syndrome


subject: CHEBI:50275

subject_name: Esomeprazole


subject: PUBCHEM.COMPOUND:118987284

subject_name: Nexium


subject: CHEBI:77260

subject_name: Omeprazole


subject: UMLS:C5784973

subject_name: Hypochlorous Acid-containing Wound Spray APR-TD011

object_name: epidermolysis bullosa


subject: UMLS:C3653501

subject_name: DIRECT ACTING ANTIVIRALS

object_name: kidney failure


subject: DRUGBANK:DB14297

subject_name: Arnica montana

object_name: Hemorrhage


subject: UMLS:C4727165

subject_name: TLR7 Agonist DSP-0509

object_name: neoplasm


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Myopia, Progressive


subject: UMLS:C1154269

subject_name: Eye drops brand of Tetrahydrozoline


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Subdural hemorrhage


subject: CHEBI:36088

subject_name: thromboxanes A


subject: UNII:63Q7F59W0V

subject_name: ATUVECICLIB

object_name: leukemia


subject: UNII:63Q7F59W0V

object_name: childhood leukemia


subject: MESH:C000625640

subject_name: atuveciclib


subject: MESH:C000625640


subject: UMLS:C4053668


subject: UMLS:C4053668


subject: CHEBI:114785

subject_name: Erlotinib

object_name: malignant soft tissue neoplasm


subject: CHEBI:114785

object_name: sarcoma


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: childhood neoplasm


subject: CHEBI:233362

object_name: neoplastic syndrome


subject: CHEBI:233362

object_name: cancer or benign tumor


subject: CHEBI:233362


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Neoplasm Metastasis


subject: CHEBI:3732


subject: CHEBI:3732


subject: CHEBI:3732


subject: CHEBI:3732


subject: CHEBI:167997

subject_name: Cellulose, microcrystalline

object_name: pervasive developmental disorder


subject: CHEBI:167997

object_name: autism


subject: CHEBI:167997

object_name: autism spectrum disorder


subject: CHEBI:62968

subject_name: Microcrystalline cellulose


subject: CHEBI:62968


subject: CHEBI:62968


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: Mycoses


subject: UMLS:C0879264


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Too early


subject: CHEBI:73604

object_name: Premature birth


subject: CHEBI:73604

object_name: Hyponatremia


subject: CHEBI:73604

object_name: Hyponatremia, CTCAE


subject: CHEBI:176724

subject_name: Etiracetam

object_name: epilepsy with generalized tonic-clonic seizures


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: GTOPDB:11827

subject_name: telitacicept


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: UMLS:C5238006


subject: PUBCHEM.COMPOUND:122527270

subject_name: bemnifosbuvir

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:122527270

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:122527270

object_name: liver cirrhosis


subject: UNII:7UM3SQL968


subject: UNII:7UM3SQL968


subject: UNII:7UM3SQL968


subject: DRUGBANK:DB19050

subject_name: Bemnifosbuvir


subject: DRUGBANK:DB19050


subject: DRUGBANK:DB19050


subject: PUBCHEM.COMPOUND:127021097

subject_name: RUZASVIR


subject: UNII:J89QT81NBQ

object_name: herpes labialis


subject: UMLS:C4490519


subject: UMLS:C4705499

object_name: rheumatoid arthritis


subject: GTOPDB:13850

subject_name: ifinatamab deruxtecan

object_name: prostate carcinoma


subject: GTOPDB:13850

object_name: prostate cancer


subject: GTOPDB:13850

object_name: prostate neoplasm


subject: UNII:C6I0GC0GX5

subject_name: IFINATAMAB DERUXTECAN


subject: UNII:C6I0GC0GX5


subject: UNII:C6I0GC0GX5


subject: UMLS:C5417871


subject: UMLS:C5417871


subject: UMLS:C5417871


subject: RXCUI:1861644

subject_name: doxylamine / pyridoxine Extended Release Oral Tablet

object_name: Morning nausea


subject: CHEBI:91366

object_name: pancreatic neoplasm


subject: CHEBI:91366

object_name: malignant pancreatic neoplasm


subject: CHEBI:91366

object_name: bladder tumor


subject: CHEBI:91366

object_name: breast neoplasm


subject: CHEBI:91366

object_name: Colon Neoplasm


subject: CHEBI:91366

object_name: benign colon neoplasm


subject: UMLS:C1831780


subject: UMLS:C1831780


subject: UMLS:C1831780


subject: UMLS:C1831780


subject: UMLS:C1831780


subject: UMLS:C1831780


subject: UMLS:C5206107

subject_name: ARC Fusion Protein SL-279252

object_name: Hodgkin Disease


subject: UMLS:C5206107

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C5206107

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C5206107

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5206107

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5206107

object_name: skin squamous cell carcinoma


subject: UMLS:C5206107


subject: UMLS:C5206107

object_name: cervical squamous cell carcinoma


subject: UMLS:C5206107

object_name: anal squamous cell carcinoma


subject: UMLS:C5206107

object_name: non-small cell lung carcinoma


subject: UMLS:C5206107

object_name: gastric adenocarcinoma


subject: UMLS:C5206107

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5206107

object_name: clear cell renal carcinoma


subject: UMLS:C5206107

object_name: renal cell adenocarcinoma


subject: UMLS:C5206107

object_name: renal cell carcinoma


subject: UMLS:C5206107

object_name: urothelial carcinoma


subject: UMLS:C5206107

object_name: transitional cell carcinoma


subject: UMLS:C5206107

object_name: melanoma


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Infection of musculoskeletal system


subject: CHEBI:474053

object_name: Fractures, Open


subject: CHEBI:3535

subject_name: Cephalexin

object_name: Infection


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: HMDB:HMDB0014735

subject_name: Gadoteridol

object_name: secondary progressive multiple sclerosis


subject: HMDB:HMDB0014735

object_name: multiple sclerosis


subject: CHEBI:31643


subject: CHEBI:31643


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: essential hypertension


subject: PUBCHEM.COMPOUND:138567123

subject_name: Baloxavir

object_name: influenza


subject: CHEBI:47426

subject_name: Furosemide

object_name: Food-Drug Interactions


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: DRUGBANK:DB16594

subject_name: Goldenseal


subject: CHEBI:6413

subject_name: Letrozole

object_name: fibrolamellar hepatocellular carcinoma


subject: CHEBI:6427

subject_name: Leuprolide


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:66660570

subject_name: Evogliptin

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C0974143

subject_name: Aloe vera gel

object_name: radiodermatitis


subject: PUBCHEM.COMPOUND:9832804

subject_name: Enstilar

object_name: skin disorder


subject: PUBCHEM.COMPOUND:9832804

object_name: psoriasis vulgaris


subject: PUBCHEM.COMPOUND:9832804

object_name: Skin and Connective Tissue Diseases


subject: PUBCHEM.COMPOUND:9832804

object_name: Skin Diseases, Papulosquamous


subject: CHEBI:90855


subject: CHEBI:90855


subject: CHEBI:90855


subject: CHEBI:90855


subject: CHEBI:50749

subject_name: Calcipotriol


subject: CHEBI:50749


subject: CHEBI:50749


subject: RXCUI:1716093

subject_name: betamethasone / calcipotriene Topical Foam


subject: RXCUI:1716093


subject: RXCUI:1716093


subject: RXCUI:1716093


subject: GTOPDB:8297

subject_name: seribantumab

object_name: Carcinoma breast stage IV


subject: UNII:1N3L70MDFX


subject: UMLS:C2703144


subject: CHEBI:8382

subject_name: Prednisone

object_name: autoimmune thrombocytopenia


subject: CHEBI:8382

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:173763

subject_name: Thermophillin

object_name: chronic pain (diagnosis)


subject: CHEBI:173763

object_name: Chronic pain


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: PUBCHEM.COMPOUND:23597337


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: Metastatic malignant neoplasm to peritoneum


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:8378

subject_name: Prednisolone

object_name: metastatic prostate carcinoma


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: non-small cell lung carcinoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Classical Hodgkin lymphoma refractory


subject: CHEBI:52717

object_name: Relapsing classical Hodgkin lymphoma


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: Poisoning by, adverse effect of and underdosing of antiviral drugs


subject: CHEBI:59902

object_name: Poisoning by antiviral drug


subject: CHEBI:59902

object_name: Adverse reaction to antiviral drugs


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: CHEBI:473990


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy


subject: PUBCHEM.COMPOUND:72370618


subject: PUBCHEM.COMPOUND:72370618


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEMBL.COMPOUND:CHEMBL2109466

object_name: Hodgkin Disease


subject: UMLS:C1881890


subject: UMLS:C0003438

subject_name: antithrombin III


subject: UMLS:C0003438

object_name: hereditary antithrombin deficiency


subject: UMLS:C0724532

subject_name: antithrombin III, human


subject: UMLS:C0724532


subject: UMLS:C0723738

subject_name: Thrombate III


subject: UMLS:C0723738


subject: UMLS:C5554963

subject_name: Multi-kinase Inhbitor AIV001

object_name: Papulopustular Rosacea


subject: CHEBI:23359

subject_name: colchicine

object_name: Atherosclerosis of arteries of the extremities


subject: PUBCHEM.COMPOUND:118981713

subject_name: onfasprodil


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Fistulising Crohn's disease


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: myocardial ischemia


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: CHEMBL.COMPOUND:CHEMBL2109506

object_name: fallopian tube carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109506

object_name: fallopian tube cancer


subject: CHEMBL.COMPOUND:CHEMBL2109506

object_name: primary peritoneal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109506

object_name: Primary Peritoneal Cancer


subject: CHEMBL.COMPOUND:CHEMBL2109506

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL2109506

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109506

object_name: ovarian carcinoma


subject: UMLS:C0879578


subject: UMLS:C0879578


subject: UMLS:C0879578


subject: UMLS:C0879578


subject: UMLS:C0879578


subject: UMLS:C0879578


subject: UMLS:C0879578


subject: CHEBI:36219

subject_name: lactose

object_name: Lipidemias


subject: CHEBI:36219

object_name: Heart Disease Risk Factors


subject: CHEBI:36219

object_name: metabolic disease


subject: CHEBI:36218

subject_name: beta-lactose


subject: CHEBI:36218


subject: CHEBI:36218


subject: UMLS:C1260222

subject_name: Saccharum lactis, Homeopathic preparation


subject: UMLS:C1260222


subject: UMLS:C1260222


subject: UMLS:C1696723

subject_name: lactose - non-drug agent


subject: UMLS:C1696723


subject: UMLS:C1696723


subject: CHEBI:135935

subject_name: Tapentadol

object_name: chronic pain (diagnosis)


subject: CHEBI:135935

object_name: Chronic pain


subject: CHEBI:135935

object_name: Knee pain


subject: CHEBI:4875

subject_name: Etanercept

object_name: stomatitis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:90528

subject_name: Neflamapimod

object_name: Alzheimer disease


subject: CHEBI:90528

object_name: mild neurocognitive disorder


subject: CHEBI:90528

object_name: mild cognitive impairment


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: chronic hepatitis B virus infection


subject: CHEBI:135915

object_name: hepatitis B


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: Knee arthropathy


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEMBL.COMPOUND:CHEMBL3545046

object_name: Cachexia


subject: UMLS:C1170167

subject_name: Cipro XR

object_name: Recurrent urinary tract infections


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:3286

subject_name: Cabergoline

object_name: type 2 diabetes mellitus


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: major depressive disorder


subject: CHEBI:8228

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:8228

object_name: metabolic syndrome X


subject: CHEBI:4672

subject_name: Docetaxel

object_name: HER2-positive gastric cancer


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: Agitation, CTCAE 3.0


subject: CHEBI:7454

object_name: Agitation


subject: CHEBI:7454

object_name: Agitation, CTCAE 5.0


subject: UMLS:C0219461

subject_name: regramostim

object_name: malignant tumor of nasopharynx


subject: CHEBI:31739

subject_name: Josamycin

object_name: Premature infant


subject: CHEBI:31739

object_name: Premature birth


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib

object_name: HER2 positive breast carcinoma


subject: CHEBI:73510

subject_name: Glu-Thr


subject: PR:000010374

subject_name: UNC93-like protein MFSD11


subject: CHEBI:2704

subject_name: Anastrozole


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:6427

subject_name: Leuprolide


subject: UNII:1000BJC8CR

subject_name: TRASTUZUMAB REZETECAN


subject: CHEBI:95341

subject_name: Baricitinib

object_name: HIV-1 infection


subject: CHEBI:9168

subject_name: Sirolimus


subject: UMLS:C4733686

object_name: IgA Nephropathy


subject: CHEBI:650917

object_name: Anorexia


subject: CHEBI:4046

subject_name: Cyproheptadine


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: neoplasm


subject: UMLS:C4044528


subject: CHEBI:5523

subject_name: Goserelin

object_name: Hodgkin Disease


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: lower extremity wound


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: head and neck squamous cell carcinoma


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: neurofibromatosis 1


subject: UNII:68AYS9A614

object_name: neurofibromatosis type 1


subject: UNII:68AYS9A614

object_name: plexiform neurofibroma


subject: UNII:68AYS9A614

object_name: neurofibroma of spinal cord


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: CHEBI:8382

subject_name: Prednisone

object_name: Hormone-dependent prostate cancer


subject: CHEBI:73323

subject_name: Ala-Ala-Pro


subject: UMLS:C0051989

subject_name: antiarrhythmic peptide


subject: PR:000014706


subject: UNII:4T36H88UA7

subject_name: Apalutamide


subject: CHEBI:63584

subject_name: Cabazitaxel


subject: CHEMBL.COMPOUND:CHEMBL4298001

subject_name: CETRELIMAB


subject: UMLS:C4329336


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:68534

subject_name: Enzalutamide


subject: UMLS:C5556649

subject_name: Anti-KLK2/CD3 Bispecific Antibody JNJ-78278343


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: CHEBI:47499

subject_name: Imipramine

object_name: Chest pain


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: adult glioblastoma


subject: CHEBI:31348

subject_name: Capecitabine

object_name: lung cancer


subject: CHEBI:31348

object_name: lung neoplasm


subject: CHEBI:31348

object_name: lung carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: glucose intolerance


subject: CHEBI:6801

object_name: Impaired glucose tolerance


subject: CHEBI:82718

subject_name: Efinaconazole

object_name: tinea unguium


subject: MESH:C539751

subject_name: ankaferd blood stopper

object_name: Teeth staining due to pulpal bleeding


subject: UMLS:C1442960

subject_name: Turkey antigen


subject: DRUGBANK:DB10575

subject_name: Turkey


subject: UMLS:C4764390

subject_name: Intuvax

object_name: Metastatic Renal Cell Cancer


subject: PUBCHEM.COMPOUND:22158442

subject_name: METHOXYVERAPAMIL

object_name: asthma


subject: CHEBI:34772

subject_name: Gallopamil


subject: UMLS:C3827169

object_name: glioma


subject: UMLS:C3827169

object_name: malignant glioma


subject: UMLS:C3827169

object_name: cholangiocarcinoma


subject: UMLS:C3827169

object_name: bone chondrosarcoma


subject: UMLS:C3827169

object_name: chondrosarcoma


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib


subject: PUBCHEM.COMPOUND:78140854


subject: PUBCHEM.COMPOUND:78140854


subject: PUBCHEM.COMPOUND:78140854


subject: PUBCHEM.COMPOUND:157010100

subject_name: Potassium citrate

object_name: urolithiasis


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: long COVID-19


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN

object_name: appendicitis


subject: UNII:X00B0D5O0E

object_name: Appendicitis, CTCAE


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:8232


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:9421


subject: CHEBI:93109

subject_name: Semaxanib

object_name: prostate carcinoma


subject: CHEBI:93109

object_name: prostate cancer


subject: UMLS:C0907160

subject_name: Pegylated Interferon Alfa

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UMLS:C0907160

object_name: diffuse intrinsic pontine glioma


subject: UNII:P6YC3EG204

subject_name: Erythrotin

object_name: vitamin B12 deficiency


subject: CHEBI:15982

subject_name: cob(I)alamin


subject: UMLS:C3714801

subject_name: Cyanocobalamin Drug Class


subject: PUBCHEM.COMPOUND:71271414

object_name: Hepatic impairment


subject: UNII:7M430JI73B


subject: UNII:2W150K0UUC

subject_name: Odevixibat

object_name: progressive familial intrahepatic cholestasis


subject: UMLS:C1710687

object_name: cancer


subject: UMLS:C1710687

object_name: neoplasm


subject: UMLS:C3661179

object_name: osteoarthritis


subject: UMLS:C0694951

subject_name: INJECTION, AMPHOTERICIN B, 50 MG ADMINISTERED

object_name: Mycoses


subject: CHEBI:64356

subject_name: Pregabalin

object_name: Fibromyalgia, Primary


subject: CHEBI:174379

object_name: nicotine dependence


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: asthma


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: Neck Carcinoma


subject: CHEBI:17549

object_name: head and neck neoplasm


subject: CHEBI:17549

object_name: head and neck cancer


subject: CHEBI:17549

object_name: precancerous condition


subject: GTOPDB:13636

subject_name: remlarsen

object_name: keloid


subject: DRUGBANK:DB19131

subject_name: Remlarsen


subject: CHEBI:30687

subject_name: osmium atom

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: CHEBI:30687

object_name: colorectal neoplasm


subject: MESH:C079198

subject_name: S 1 (combination)


subject: MESH:C079198


subject: UNII:3HP012Q0FH

object_name: cystoid macular edema


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: adult lymphoma


subject: UNII:M89N0Q7EQR

object_name: lymphoma


subject: UNII:M89N0Q7EQR

object_name: pediatric lymphoma


subject: UMLS:C3539881

subject_name: gamma-interferon


subject: UMLS:C3539881


subject: UMLS:C3539881


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: multiple sclerosis


subject: UNII:4F4X42SYQ6

object_name: autoimmune disorder of the nervous system


subject: UNII:4F4X42SYQ6

object_name: demyelinating disease


subject: UNII:4F4X42SYQ6

object_name: nervous system disorder


subject: UNII:4F4X42SYQ6

object_name: CNS demyelinating autoimmune disease


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:135948

subject_name: Amifampridine

object_name: Acquired nystagmus


subject: UMLS:C4042779

object_name: COPD, severe early onset


subject: CHEBI:48299

subject_name: Erythritol

object_name: Heart Disease Risk Factors


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol


subject: CHEBI:17151


subject: UMLS:C5239418

object_name: Childhood Solid Neoplasm


subject: UMLS:C5239418

object_name: Adult Solid Neoplasm


subject: UMLS:C5239418

object_name: Solid Neoplasm


subject: UMLS:C4725919

subject_name: MEK Inhibitor SHR 7390


subject: UMLS:C4725919


subject: UMLS:C4725919


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Hemorrhage


subject: UMLS:C1135142

subject_name: Metvix

object_name: actinic keratosis


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: outcomes general quality of life


subject: CHEBI:3160

object_name: Perceived quality of life


subject: CHEBI:3160

object_name: Good quality of life


subject: CHEBI:3160

object_name: Anticholinergic Syndrome


subject: CHEBI:3160

object_name: urinary system disorder


subject: UNII:JH368G5B9M

subject_name: Tucaresol

object_name: HIV infection


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Retinal Pigment Epithelial Detachment


subject: UNII:B68083E4YG


subject: UNII:B68083E4YG


subject: UNII:B68083E4YG


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Conn's syndrome


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Chronic pelvic pain of female


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Advanced Gastric Adenocarcinoma


subject: CHEBI:231614

object_name: Advanced Esophageal Adenocarcinoma


subject: CHEBI:231614

object_name: Esophageal adenocarcinoma stage IV


subject: CHEBI:231614

object_name: Unresectable Esophageal Adenocarcinoma


subject: CHEBI:231614

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:231614

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:231614

object_name: Unresectable Gastric Adenocarcinoma


subject: CHEBI:231614

object_name: Clinical Stage IV Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:231614

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:231614

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:131674970

subject_name: CEFTRIAXONE SODIUM

object_name: Abdominal Infection


subject: CHEBI:3514

subject_name: Ceftriaxone disodium salt hemiheptahydrate


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: brain glioblastoma


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Nutritional status


subject: MESH:D014131

subject_name: Trace Elements


subject: UMLS:C0282575

subject_name: Micronutrients


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: septic shock


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: Chronic small plaque psoriasis


subject: UNII:UMD07X179E

object_name: psoriasis


subject: UMLS:C1172157


subject: UMLS:C1172157


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: scleroderma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: GTOPDB:4934

subject_name: G-CSF

object_name: systemic sclerosis


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C0085297


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: CHEBI:27470

subject_name: Folic acid

object_name: cleft lip


subject: CHEBI:27470

object_name: Cleft lip


subject: CHEBI:27470

object_name: cleft palate


subject: CHEBI:27470

object_name: isolated cleft palate


subject: CHEBI:27470

object_name: cleft palate on exam


subject: MESH:C549320

subject_name: MVA 85A

object_name: HIV infection


subject: UMLS:C2933875

subject_name: AERAS 485


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: High Risk Neuroblastoma


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: Fractured facial bone


subject: CHEBI:9168

subject_name: Sirolimus

object_name: eosinophilic gastroenteritis


subject: CHEBI:9168

object_name: eosinophilic esophagitis


subject: CHEBI:9168

object_name: Eosinophilic infiltration of the esophagus


subject: UNII:SGW6W5758V

subject_name: Imrecoxib

object_name: osteoarthritis, knee


subject: CHEBI:114785

subject_name: Erlotinib

object_name: nephroblastoma


subject: CHEBI:114785

object_name: Wilms tumor


subject: CHEBI:114785

object_name: childhood kidney Wilms tumor


subject: CHEBI:114785

object_name: primitive neuroectodermal tumor


subject: CHEBI:114785

object_name: peripheral primitive neuroectodermal tumor


subject: CHEBI:114785

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:114785

object_name: rhabdomyosarcoma


subject: CHEBI:114785

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:114785

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:114785

object_name: medulloblastoma


subject: CHEBI:114785

object_name: childhood medulloblastoma


subject: CHEBI:114785

object_name: adult medulloblastoma


subject: CHEBI:114785

object_name: Ewing sarcoma


subject: CHEBI:114785

object_name: pediatric osteosarcoma


subject: CHEBI:114785

object_name: Osteosarcoma


subject: CHEBI:114785

object_name: glioma susceptibility 1


subject: CHEBI:114785

object_name: ependymoma


subject: CHEBI:114785

object_name: childhood ependymoma


subject: CHEBI:114785

object_name: Newly Diagnosed Childhood Ependymoma


subject: CHEBI:114785

object_name: Adult Ependymoma


subject: CHEBI:114785

object_name: glioma


subject: CHEBI:114785

object_name: malignant glioma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: primitive neuroectodermal tumor


subject: UMLS:C0919079

object_name: peripheral primitive neuroectodermal tumor


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:135919

subject_name: Nesiritide

object_name: dilated cardiomyopathy


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: Childhood Kidney Disorder


subject: CHEBI:94686

subject_name: Orlistat

object_name: hepatitis A


subject: CHEBI:94686

object_name: hepatitis


subject: CHEBI:94686

object_name: Fatty Liver


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Delayed Graft Function


subject: CHEBI:5775

subject_name: Hydralazine

object_name: lung cancer


subject: CHEBI:5775

object_name: lung neoplasm


subject: CHEBI:5775

object_name: lung carcinoma


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Advanced renal cell carcinoma


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Sarcopenic obesity


subject: UMLS:C0356365

subject_name: Insulin, Short-Acting

object_name: type 2 diabetes mellitus


subject: UMLS:C0356365

object_name: Diabetes


subject: UMLS:C0356365

object_name: diabetes mellitus


subject: UMLS:C0021641

subject_name: Insulin


subject: CHEBI:94534

subject_name: olanzapine

object_name: Vomiting, CTCAE


subject: CHEBI:94534

object_name: Vomiting


subject: CHEBI:94534

object_name: Nausea, CTCAE_5


subject: CHEBI:94534

object_name: Nausea


subject: CHEBI:94534

object_name: Nausea, CTCAE_3


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: Alzheimer disease type 1


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: urothelial carcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: transitional cell carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: PUBCHEM.COMPOUND:86821

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:86821

object_name: metabolic syndrome X


subject: CHEBI:26125

subject_name: phytosterols


subject: CHEBI:26125


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: osteogenesis imperfecta


subject: UMLS:C1530450

subject_name: AMG 162


subject: UNII:U6CKL88C8H

subject_name: GOCATAMIG

object_name: small cell lung carcinoma


subject: UMLS:C5446875

subject_name: Gocatamig


subject: GTOPDB:13850

subject_name: ifinatamab deruxtecan


subject: UNII:C6I0GC0GX5

subject_name: IFINATAMAB DERUXTECAN


subject: UMLS:C5417871


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: acute coronary syndrome


subject: CHEBI:85078

object_name: Ventricular Dysfunction


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: Stage III Pancreatic Cancer AJCC v8


subject: HMDB:HMDB0256702

object_name: Pancreatic carcinoma stage III


subject: HMDB:HMDB0256702

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: HMDB:HMDB0256702

object_name: pancreatic acinar cell carcinoma


subject: HMDB:HMDB0256702

object_name: pancreatic ductal adenocarcinoma


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: CHEBI:149504

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:149504

object_name: COPD, severe early onset


subject: CHEBI:149504

object_name: chronic obstructive pulmonary disease


subject: CHEBI:149504

object_name: chronic bronchitis


subject: CHEBI:149504

object_name: bronchitis


subject: CHEBI:149504

object_name: emphysema


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:85078

object_name: Chronic uremia


subject: CHEBI:85078

object_name: Complication of peritoneal dialysis


subject: CHEBI:17688

subject_name: Nicotine

object_name: colorectal cancer


subject: CHEBI:17688

object_name: colorectal carcinoma


subject: CHEBI:17688

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:17688

object_name: prostate carcinoma


subject: CHEBI:17688

object_name: prostate cancer


subject: CHEBI:17688

object_name: Childhood Breast Carcinoma


subject: CHEBI:17688

object_name: breast carcinoma


subject: CHEBI:17688

object_name: breast cancer


subject: CHEBI:17688

object_name: bladder tumor


subject: CHEBI:17688

object_name: urinary bladder carcinoma


subject: CHEBI:17688

object_name: urinary bladder cancer


subject: CHEBI:17688

object_name: childhood bladder carcinoma


subject: CHEBI:17688

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:17688

object_name: testicular germ cell tumor 1


subject: CHEBI:17688

object_name: testicular germ cell tumor


subject: CHEBI:17688

object_name: childhood testicular germ cell tumor


subject: CHEBI:17688

object_name: adult lymphoma


subject: CHEBI:17688

object_name: lymphoma


subject: CHEBI:17688

object_name: pediatric lymphoma


subject: UMLS:C0950801

object_name: OPTN-related open angle glaucoma


subject: UMLS:C0950801

object_name: open-angle glaucoma


subject: UMLS:C0950801

object_name: ocular hypertension


subject: UMLS:C0950801

object_name: Ocular hypertension


subject: CHEBI:63925

subject_name: PhXa 85


subject: CHEBI:38940

subject_name: Sunitinib

object_name: thyroid gland carcinoma


subject: CHEBI:184662


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:90001

subject_name: cystathionine ketimine


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Lung squamous cell carcinoma recurrent


subject: CHEBI:4672

object_name: Stage IV Lung Squamous Cell Carcinoma AJCC v7


subject: CHEBI:4672

object_name: CDK4 Gene Amplification


subject: CHEBI:4672

object_name: CCND2 Gene Amplification


subject: CHEBI:4672

object_name: CCND1 Gene Amplification


subject: CHEBI:4672

object_name: CCND3 Gene Amplification


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:156861524

subject_name: monlunabant

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:156861524

object_name: obesity


subject: PUBCHEM.COMPOUND:156861524

object_name: Obesity, CTCAE


subject: UNII:4G8X27X87A

subject_name: MONLUNABANT


subject: UNII:4G8X27X87A


subject: UNII:4G8X27X87A


subject: UMLS:C5910070

subject_name: Monlunabant


subject: UMLS:C5910070


subject: UMLS:C5910070


subject: PUBCHEM.COMPOUND:24181126

subject_name: Fluorescite

object_name: atrial septal defect


subject: CHEBI:172923

subject_name: FLUORESCEIN


subject: UMLS:C0720479


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: bladder tumor


subject: UNII:6A901E312A

object_name: urinary bladder carcinoma


subject: UNII:6A901E312A

object_name: urinary bladder cancer


subject: UNII:6A901E312A

object_name: childhood bladder carcinoma


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Delusion of reference


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: nephrotic syndrome


subject: PUBCHEM.COMPOUND:73151030

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:6121

subject_name: Ketamine

object_name: Neck Carcinoma


subject: CHEBI:6121

object_name: head and neck neoplasm


subject: CHEBI:6121

object_name: head and neck cancer


subject: CHEBI:6121

object_name: mucositis


subject: CHEBI:119486

subject_name: Efavirenz

object_name: Adverse drug interaction


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: chronic rhinosinusitis with nasal polyps


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:42944

subject_name: Galantamine

object_name: Memory observations


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB

object_name: non-small cell lung carcinoma


subject: UMLS:C4764272

subject_name: Botensilimab


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB


subject: UMLS:C4526708


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: small cell lung carcinoma


subject: UMLS:C4331912


subject: PUBCHEM.COMPOUND:164809721

subject_name: Aleniglipron

object_name: Overweight


subject: PUBCHEM.COMPOUND:164809721

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:164809721

object_name: obesity


subject: PUBCHEM.COMPOUND:164809721

object_name: Obesity, CTCAE


subject: UNII:Z6XCL6R9SX

subject_name: ALENIGLIPRON


subject: UNII:Z6XCL6R9SX


subject: UNII:Z6XCL6R9SX


subject: UNII:Z6XCL6R9SX


subject: CHEBI:84040

object_name: lymphangioleiomyomatosis


subject: CHEBI:84040

object_name: lung lymphangioleiomyomatosis


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Facial Expression


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:39548

object_name: chronic kidney disease


subject: CHEBI:32139


subject: GTOPDB:13535

subject_name: drisapersen

object_name: Duchenne muscular dystrophy


subject: CHEMBL.COMPOUND:CHEMBL2108735

subject_name: DRISAPERSEN


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: carcinoma of esophagus


subject: GTOPDB:13085

object_name: esophageal cancer


subject: GTOPDB:13085

object_name: Childhood Esophageal Carcinoma


subject: GTOPDB:13085

object_name: neoplasm of esophagus


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UNII:05FZV98342

subject_name: Inecalcitol


subject: UNII:05FZV98342


subject: UNII:05FZV98342


subject: UNII:05FZV98342


subject: UniProtKB:P0AEW4

subject_name: CPDA_ECOLI 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA (sprot)


subject: UniProtKB:P0AEW4


subject: UniProtKB:P0AEW4


subject: UniProtKB:P0AEW4


subject: PR:000022988

subject_name: protein icc


subject: PR:000022988


subject: PR:000022988


subject: PR:000022988


subject: PR:000007559

object_name: Anemia in end stage renal disease


subject: UMLS:C2917382

subject_name: Erythropoiesis-stimulating Agent [EPC]


subject: CHEBI:51141

subject_name: Alfuzosin

object_name: nephrolithiasis, calcium oxalate


subject: CHEBI:51141

object_name: nephrolithiasis


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Myopic choroidal neovascularization


subject: UMLS:C4291400

subject_name: Vaxchora

object_name: cholera


subject: UMLS:C4685005

subject_name: Tebotelimab

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4685005

object_name: Neck Carcinoma


subject: UMLS:C4685005

object_name: head and neck neoplasm


subject: UMLS:C4685005

object_name: head and neck cancer


subject: GTOPDB:9589

subject_name: enoblituzumab


subject: GTOPDB:9589


subject: GTOPDB:9589


subject: GTOPDB:9589


subject: CHEMBL.COMPOUND:CHEMBL3545373

subject_name: ENOBLITUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: DRUGBANK:DB17781

object_name: Ebola hemorrhagic fever


subject: UMLS:C5815621


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Post-Operative Pain


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Carcinoma breast stage IV


subject: UMLS:C2346793

subject_name: carlumab

object_name: cancer


subject: UMLS:C2346793

object_name: neoplasm


subject: UMLS:C4760860

object_name: mantle cell lymphoma


subject: UMLS:C5391732

object_name: supranuclear palsy, progressive, 1


subject: UMLS:C5391732

object_name: progressive supranuclear palsy


subject: GTOPDB:7983

subject_name: lintuzumab

object_name: leukemia


subject: GTOPDB:7983

object_name: childhood leukemia


subject: CHEMBL.COMPOUND:CHEMBL2109150

subject_name: LINTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109150


subject: UMLS:C0530093


subject: UMLS:C0530093


subject: CHEBI:184662

object_name: coronary microvascular disorder


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: PUBCHEM.COMPOUND:266052

subject_name: Vitamin

object_name: swine influenza


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C3853900

object_name: pancreatic neoplasm


subject: UMLS:C3853900

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3853900

object_name: malignant pancreatic neoplasm


subject: CHEBI:25805

subject_name: oxygen atom

object_name: interstitial lung disease 1


subject: CHEBI:25805

object_name: interstitial lung disease 2


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: peanut allergy


subject: CHEBI:8774

subject_name: Ramipril

object_name: Alport syndrome


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: colorectal cancer


subject: CHEBI:89324

object_name: colorectal carcinoma


subject: CHEBI:89324

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: HIV infection


subject: CHEBI:3311

subject_name: Calcium carbonate


subject: CHEBI:89324


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842


subject: UMLS:C3537249


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Childhood Pineoblastoma


subject: CHEBI:70839

object_name: pineoblastoma


subject: CHEBI:70839

object_name: adult pineoblastoma


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEMBL.COMPOUND:CHEMBL2109608

object_name: Locally Advanced Basal Cell Carcinoma


subject: UMLS:C2983744

subject_name: Darleukin


subject: CHEBI:60799

subject_name: Esketamine

object_name: endometriosis


subject: CHEBI:60799

object_name: Chronic pelvic pain syndrome


subject: UMLS:C0751598

subject_name: Alferon

object_name: plasma cell myeloma


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: intermediate uveitis


subject: UNII:I031V2H011

object_name: choroiditis


subject: UNII:I031V2H011

object_name: posterior uveitis


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C1709443

subject_name: Rose Bengal Solution PV-10

object_name: liver carcinoma


subject: UMLS:C1709443

object_name: metastatic melanoma


subject: UMLS:C1709443

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C1709443

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C1709443

object_name: Carcinoma breast stage IV


subject: UMLS:C1709443

object_name: Metastatic ocular melanoma


subject: UMLS:C1709443

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C1709443

object_name: metastatic colorectal cancer


subject: UMLS:C1709443

object_name: Metastatic Uveal Melanoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Adult Meningioma


subject: UNII:KXG2PJ551I

object_name: benign meningioma


subject: UNII:KXG2PJ551I

object_name: familial meningioma


subject: UNII:KXG2PJ551I

object_name: pediatric meningioma


subject: UNII:KXG2PJ551I

object_name: meningioma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib

object_name: Refractory Rhabdoid Tumor


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Osteosarcoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Ependymoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Rhabdoid Tumor


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Ewing Sarcoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Ependymoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Childhood Ependymoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Neuroblastoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Langerhans Cell Histiocytosis


subject: PUBCHEM.COMPOUND:78140854

object_name: Ewing's sarcoma recurrent


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Malignant Glioma


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Hepatoblastoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:78140854

object_name: Osteosarcoma recurrent


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Langerhans Cell Histiocytosis


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Medulloblastoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Neuroblastoma recurrent


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Childhood Malignant Germ Cell Tumor


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Malignant Germ Cell Tumor


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory WHO Grade 2 Glioma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Malignant Glioma


subject: PUBCHEM.COMPOUND:78140854

object_name: Hepatoblastoma recurrent


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Malignant Germ Cell Tumor


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Medulloblastoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Childhood Medulloblastoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent WHO Grade 2 Glioma


subject: PUBCHEM.COMPOUND:78140854

object_name: nephroblastoma


subject: PUBCHEM.COMPOUND:78140854

object_name: Wilms tumor


subject: PUBCHEM.COMPOUND:78140854

object_name: childhood kidney Wilms tumor


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Peripheral Primitive Neuroectodermal Tumor


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory Peripheral Primitive Neuroectodermal Tumor


subject: CHEBI:9168

object_name: squamous cell carcinoma


subject: CHEBI:9168

object_name: head and neck neoplasm


subject: CHEBI:9168

object_name: tongue cancer


subject: CHEBI:9168

object_name: tongue neoplasm


subject: CHEBI:9168

object_name: mouth neoplasm


subject: UMLS:C0348081

subject_name: Candida albicans antigen

object_name: Normal Skin


subject: CHEBI:18295

subject_name: Histamine


subject: CHEBI:36704

subject_name: Imiquimod


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C1170024

subject_name: Adderall-XR

object_name: endogenous depression


subject: UMLS:C1170024

object_name: major depressive disorder


subject: CHEBI:305790

subject_name: thyroxine

object_name: Intraventricular hemorrhage of prematurity


subject: CHEBI:18332

subject_name: Levothyroxine


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Carcinoma breast stage IV


subject: UMLS:C3641122


subject: UMLS:C1384659

object_name: head and neck squamous cell carcinoma


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Congenital heart disease in children


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: metastatic prostate carcinoma


subject: CHEBI:4026

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVA Prostate Cancer AJCC v8


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UNII:98BSN6N516

subject_name: Rogaratinib

object_name: neoplasm


subject: UMLS:C5198671


subject: UMLS:C5400622

subject_name: Gam-COVID-Vac

object_name: SARS-CoV-2 acute respiratory disease


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: Alzheimer disease


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: diffuse large B-cell lymphoma


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: UNII:6C9UKZ0CYE

object_name: heart failure


subject: UNII:6C9UKZ0CYE

object_name: Heart Failure, CTCAE


subject: UMLS:C0042210

subject_name: Vaccines

object_name: meningococcal infection


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Recurrent Pancreatic Neuroendocrine Carcinoma


subject: CHEBI:71219

object_name: gastrinoma


subject: CHEBI:71219

object_name: somatostatinoma


subject: CHEBI:71219

object_name: Regional Digestive System Neuroendocrine Tumor G1


subject: CHEBI:71219

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:71219

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:71219

object_name: lung carcinoid tumor


subject: CHEBI:71219

object_name: multiple endocrine neoplasia type 1


subject: CHEBI:71219

object_name: PPoma


subject: CHEBI:71219

object_name: glucagonoma


subject: CHEBI:71219

object_name: insulinoma


subject: UMLS:C5964811

object_name: blood coagulation disease


subject: UMLS:C5964811

object_name: myeloproliferative neoplasm


subject: UMLS:C5964811

object_name: essential thrombocythemia


subject: UMLS:C5964811

object_name: inherited bleeding disorder, platelet-type


subject: UMLS:C5964811

object_name: blood platelet disease


subject: UMLS:C5964811

object_name: hemorrhagic disease


subject: UMLS:C5964811

object_name: bone marrow disorder


subject: UMLS:C5964811

object_name: hematologic disorder


subject: UMLS:C5964811

object_name: acquired polycythemia vera


subject: UMLS:C5964811

object_name: thrombocytosis


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069

object_name: myelofibrosis


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Cutaneous Merkel Cell Carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:75722

subject_name: Tramadol

object_name: post-traumatic stress disorder


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: acute myocardial infarction


subject: CHEBI:38545

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:6121

subject_name: Ketamine

object_name: ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder


subject: CHEBI:8499

subject_name: Propranolol

object_name: cervical cancer


subject: CHEBI:8499

object_name: cervical carcinoma


subject: UMLS:C5706415

subject_name: Personalized Neoantigen Vaccine NECVAX NEO1

object_name: Childhood Solid Neoplasm


subject: UMLS:C5706415

object_name: Adult Solid Neoplasm


subject: UMLS:C5706415

object_name: Solid Neoplasm


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: meningitis


subject: DRUGBANK:DB19249

object_name: Meningitis, CTCAE


subject: DRUGBANK:DB19249

object_name: Sepsis


subject: DRUGBANK:DB19249

object_name: Sepsis, CTCAE


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: UMLS:C5222498

subject_name: Secukinumab Liquid Injection

object_name: lamellar ichthyosis


subject: UMLS:C5222498

object_name: inherited ichthyosis


subject: UMLS:C5222498

object_name: Congenital ichthyosiform erythroderma


subject: UMLS:C5203458

subject_name: Ustekinumab Liquid Injection


subject: UMLS:C5203458


subject: UMLS:C5203458


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab


subject: UNII:FU77B4U5Z0


subject: UNII:FU77B4U5Z0


subject: CHEBI:94686

subject_name: Orlistat

object_name: female infertility


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: dyspepsia


subject: CHEBI:2676

object_name: Dyspepsia, CTCAE


subject: CHEBI:188602

subject_name: Seletracetam

object_name: focal epilepsy


subject: CHEBI:10093

subject_name: Yohimbine

object_name: type 2 diabetes mellitus


subject: UMLS:C2355103

object_name: Injury of kidney


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: female reproductive organ cancer


subject: PUBCHEM.COMPOUND:173480

object_name: endogenous depression


subject: UMLS:C3896652


subject: CHEBI:27656

subject_name: Camptothecin

object_name: post-traumatic stress disorder


subject: MESH:C000708228


subject: UMLS:C0006938

subject_name: captopril


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Adverse anesthesia outcome


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:76128

subject_name: Dexketoprofen


subject: CHEBI:62088

subject_name: Metamizole


subject: CHEBI:41948

subject_name: Eflornithine

object_name: Childhood Astrocytoma


subject: CHEBI:41948

object_name: glioma susceptibility 1


subject: CHEBI:41948

object_name: astrocytic tumor


subject: CHEBI:41948

object_name: astrocytoma


subject: CHEBI:41948

object_name: glioblastoma


subject: CHEBI:41948

object_name: Childhood Glioblastoma


subject: CHEBI:41948

object_name: adult glioblastoma


subject: CHEBI:41948

object_name: IDH-mutant anaplastic astrocytoma


subject: CHEBI:41948

object_name: IDH-wildtype glioblastoma


subject: CHEBI:41948

object_name: Brain Stem Glioblastoma


subject: CHEBI:41948

object_name: Glioblastoma isocitrate dehydrogenase wildtype


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:5779

subject_name: Hydrocodone

object_name: Presenile dementia


subject: CHEBI:5779

object_name: dementia


subject: CHEBI:5779

object_name: vascular dementia


subject: CHEBI:5779

object_name: Alzheimer disease type 1


subject: CHEBI:5779

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:22227703

subject_name: Loteprednol etabonate

object_name: Dry Eye, CTCAE


subject: PUBCHEM.COMPOUND:22227703

object_name: Dryness of eye


subject: CHEBI:50848

subject_name: Loteprednol


subject: CHEBI:50848


subject: PUBCHEM.COMPOUND:3384

subject_name: Fluoromethalone

object_name: dry eye syndrome


subject: PUBCHEM.COMPOUND:3384


subject: PUBCHEM.COMPOUND:3384


subject: CHEBI:31625

subject_name: Fluorometholone


subject: CHEBI:31625


subject: CHEBI:31625


subject: UMLS:C5238346

subject_name: Davutamig

object_name: non-small cell lung carcinoma


subject: CHEBI:174615

object_name: Severe Aplastic Anemia


subject: CHEBI:174615

object_name: severe aplastic anemia


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: chronic obstructive pulmonary disease


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:94531

subject_name: belinostat

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:94531

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:94531

object_name: follicular lymphoma


subject: CHEBI:94531

object_name: mantle cell lymphoma


subject: CHEBI:94531

object_name: diffuse large B-cell lymphoma


subject: CHEBI:94531

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:94531

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:6096882

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: thyroid cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: goiter


subject: PUBCHEM.COMPOUND:6096882

object_name: Graves disease


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:3139

subject_name: bleomycin

object_name: vulva cancer


subject: CHEBI:3139

object_name: vulva carcinoma


subject: PUBCHEM.COMPOUND:16170201

subject_name: TEICOPLANIN

object_name: bacterial infectious disease


subject: CHEBI:70746

subject_name: Dabigatran etexilate


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:94366

subject_name: itraconazole


subject: PUBCHEM.COMPOUND:134304734

subject_name: Zagociguat

object_name: schizophrenia


subject: UMLS:C5853987


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: CD4+/CD56+ hematodermic neoplasm


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:231683

subject_name: Anakinra

object_name: pericarditis


subject: CHEBI:231683

object_name: Pericarditis, CTCAE


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: CHEBI:6801

subject_name: Metformin

object_name: Depressed mood


subject: CHEBI:6801

object_name: Cancer patients and suicide and depression


subject: CHEBI:6801

object_name: Depressed - symptom


subject: CHEBI:6801

object_name: Depression, CTCAE


subject: CHEBI:37845

subject_name: growth hormone

object_name: metabolic disease


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:16349

subject_name: Citrulline

object_name: malaria


subject: CHEBI:16349

object_name: Pregnant


subject: CHEBI:16349

object_name: Premature birth


subject: CHEBI:16349

object_name: fetal growth restriction


subject: CHEBI:16349

object_name: Nutritional status


subject: MESH:C587319

object_name: hyperlipidemia


subject: MESH:C587319

object_name: hyperlipoproteinemia


subject: MESH:C587319

object_name: Hyperlipidemia, CTCAE


subject: MESH:C587319

object_name: Serum lipids high (finding)


subject: UMLS:C3485426

subject_name: MenHibrix

object_name: meningococcal infection


subject: UNII:D8A4Z52D1J

object_name: Presenile dementia


subject: UNII:D8A4Z52D1J

object_name: dementia


subject: PUBCHEM.COMPOUND:11236066

subject_name: BRIMONIDINE TARTRATE

object_name: OPTN-related open angle glaucoma


subject: PUBCHEM.COMPOUND:11236066

object_name: drugs; glaucoma


subject: CHEBI:4315

subject_name: Danazol

object_name: endometrial cancer


subject: CHEBI:4315

object_name: uterine corpus cancer


subject: CHEBI:4315

object_name: endometrial carcinoma


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: breast neoplasm


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: atopic eczema


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:90881

subject_name: Camptosar

object_name: colorectal neoplasm


subject: UNII:4613T5ZY7G

subject_name: inosine dialdehyde

object_name: acute lymphoblastic leukemia


subject: CHEBI:24786

subject_name: iminodiacetic acid


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: heart disorder


subject: MESH:D000082082

object_name: endocrine system disorder


subject: MESH:D000082082

object_name: Autoimmunity


subject: MESH:D000082082

object_name: cancer


subject: MESH:D000082082

object_name: neoplasm


subject: MESH:D000082082

object_name: disorder of orbital region


subject: MESH:D000082082

object_name: eye disorder


subject: MESH:D000082082

object_name: neuropathy


subject: MESH:D000082082

object_name: arthritis


subject: MESH:D000082082

object_name: Arthritis, CTCAE


subject: MESH:D000082082

object_name: juvenile dermatomyositis


subject: MESH:D000082082

object_name: myositis


subject: MESH:D000082082

object_name: Myositis, CTCAE 5.0


subject: CHEBI:135914

subject_name: carperitide

object_name: acute myocardial infarction


subject: CHEBI:135914

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:80233

subject_name: Atrial natriuretic peptide


subject: CHEBI:80233


subject: CHEBI:147420

subject_name: ammonium nitrate phosphate


subject: CHEBI:147420


subject: PR:000011374

subject_name: atrial natriuretic factor


subject: PR:000011374


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: Neck Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: head and neck neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: head and neck cancer


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: carcinoma of esophagus


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: esophageal cancer


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: Childhood Esophageal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: neoplasm of esophagus


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: renal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: kidney neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: kidney cancer


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: glioma


subject: CHEBI:55438

subject_name: Angiotensin 1-7

object_name: peripheral vascular disease


subject: CHEBI:55438

object_name: peripheral arterial disease


subject: UMLS:C0103306


subject: UMLS:C0103306


subject: PR:000036013

subject_name: angiotensin 1-7


subject: PR:000036013


subject: UMLS:C2984208

subject_name: PARP Inhibitor E7016

object_name: Solid Neoplasm


subject: CHEBI:35674

subject_name: antihypertensive agent

object_name: essential hypertension


subject: CHEBI:35674

object_name: cardiovascular disorder


subject: UMLS:C0003364

subject_name: Antihypertensive Agents


subject: UMLS:C0003364


subject: PUBCHEM.COMPOUND:135483998

object_name: Parkinson disease


subject: CHEBI:136009

subject_name: L-Methylfolate


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C1122231

subject_name: BIBR 1048

object_name: venous thromboembolism


subject: UMLS:C1122231

object_name: thrombophilia due to thrombin defect


subject: UMLS:C3859612

subject_name: Hyqvia

object_name: multifocal motor neuropathy


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Clear-cell metastatic renal cell carcinoma


subject: CHEBI:71219

subject_name: Pazopanib


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C3896806


subject: CHEBI:66910

subject_name: Axitinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:66910


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:18361

object_name: Heartburn


subject: CHEBI:53266

subject_name: poly(propylene imine) macromolecule


subject: CHEBI:35782

subject_name: diphosphate ion


subject: CHEBI:60614

subject_name: poly(propylene imine) polymer


subject: CHEBI:29888

subject_name: Pyrophosphate


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: CHEBI:67271

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:67271

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:67271

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: CHEBI:67271

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: CHEBI:67271

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: CHEBI:67271

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:7726

subject_name: octreotide

object_name: migraine


subject: CHEBI:95021

subject_name: pemetrexed

object_name: type C thymoma


subject: CHEBI:95021

object_name: thymoma


subject: CHEBI:95021

object_name: thymus neoplasm


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: UNII:T7Q0XY74OK

object_name: heart failure


subject: UNII:T7Q0XY74OK

object_name: Heart Failure, CTCAE


subject: UNII:2B218X5QIY

object_name: schizophrenia


subject: UMLS:C4329334

subject_name: Ezabenlimab

object_name: Adult Solid Neoplasm


subject: UMLS:C5555578


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:31348

object_name: HER2/Neu Negative


subject: CHEBI:31348

object_name: Estrogen Receptor Negative


subject: CHEBI:31348

object_name: Progesterone Receptor Negative


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:DPT0O3T46P

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Breast cancer recurrent


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: heart failure


subject: UNII:1C6V77QF41

object_name: Heart Failure, CTCAE


subject: CHEBI:144094

subject_name: bicalutamide

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:71219

subject_name: Pazopanib


subject: CHEBI:71219

object_name: Prostate cancer recurrent


subject: UMLS:C2932376

subject_name: XOMA 052

object_name: rheumatoid arthritis


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: uveitis


subject: UNII:ZL1R02VT79

object_name: Uveitis, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: cholera


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:91899

object_name: COPD exacerbation


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:408174

subject_name: Arformoterol


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Sepsis


subject: CHEBI:38545

object_name: Sepsis, CTCAE


subject: UNII:0XT2CPR891

subject_name: BEFOTERTINIB

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB18844

subject_name: Befotertinib


subject: UMLS:C5854555

subject_name: Anti-CD20/Anti-CD3 Bispecific Antibody MBS303

object_name: non-Hodgkin lymphoma


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: HIV-1 infection


subject: UMLS:C1515426

subject_name: Zadaxin


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: stage IIB rectal cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIB Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIA Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIC Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IIIA rectal cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:42588

subject_name: Fenretinide

object_name: prostate carcinoma


subject: CHEBI:42588

object_name: prostate cancer


subject: GTOPDB:5063

subject_name: thrombopoietin

object_name: vascular hemostatic disease


subject: UNII:5651J3R2JF

subject_name: THROMBOPOIETIN


subject: UNII:O14Q7A13PT


subject: UNII:HM5641GA6F

subject_name: Oprelvekin


subject: CHEBI:151315

subject_name: Heparin


subject: KEGG.COMPOUND:C00374


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: borderline personality disorder


subject: PUBCHEM.COMPOUND:132222602

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:132222602

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:132222602

object_name: esophageal squamous cell carcinoma


subject: PUBCHEM.COMPOUND:132222602

object_name: non-small cell lung carcinoma


subject: UNII:V6Q7413SA8


subject: UNII:V6Q7413SA8


subject: UNII:V6Q7413SA8


subject: UNII:V6Q7413SA8


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: PUBCHEM.COMPOUND:3685

object_name: Acute myeloid leukemia in remission


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: rectal carcinoma


subject: CHEBI:9398

object_name: rectal cancer


subject: CHEBI:9398

object_name: Childhood Rectal Carcinoma


subject: UMLS:C5814313

object_name: pyruvate kinase deficiency of red cells


subject: UMLS:C4722362

object_name: colorectal cancer


subject: UMLS:C4722362

object_name: colorectal carcinoma


subject: UMLS:C4722362

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:135515

subject_name: Bendamustine

object_name: diffuse large B-cell lymphoma


subject: CHEBI:135515

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:135515

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C2934194

subject_name: BI 1744 CL

object_name: COPD, severe early onset


subject: UMLS:C2934194

object_name: chronic obstructive pulmonary disease


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: prostate adenocarcinoma


subject: UMLS:C3827082


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: prostate carcinoma


subject: UNII:I031V2H011

object_name: prostate cancer


subject: UNII:I031V2H011


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: acne


subject: CHEBI:84094

object_name: Transsexualism


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:474053

subject_name: Cefazolin

object_name: staphylococcus aureus infection


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:49566

subject_name: Cloxacillin


subject: CHEBI:5098

subject_name: Flucloxacillin


subject: CHEBI:63607

subject_name: Linezolid


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: UMLS:C0041044


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: UMLS:C0042210

subject_name: Vaccines

object_name: childhood malignant neoplasm


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: leukemia


subject: UNII:M89N0Q7EQR

object_name: childhood leukemia


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:15570

subject_name: D-Alanine

object_name: disease (or disorder); serum


subject: CHEBI:15570

object_name: arteriosclerosis disorder


subject: CHEBI:15570

object_name: atherosclerosis


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:46217


subject: CHEBI:46217


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:16449


subject: CHEBI:16449


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:16977


subject: CHEBI:16977


subject: CHEBI:32696


subject: CHEBI:32696


subject: CHEBI:32696


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: PUBCHEM.COMPOUND:53395091


subject: PUBCHEM.COMPOUND:53395091


subject: PUBCHEM.COMPOUND:53395091


subject: CHEBI:16375

subject_name: D-Cysteine


subject: CHEBI:16375


subject: CHEBI:16375


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:15966

subject_name: D-Glutamic Acid


subject: CHEBI:15966


subject: CHEBI:15966


subject: CHEBI:14321


subject: CHEBI:14321


subject: CHEBI:14321


subject: CHEBI:29987


subject: CHEBI:29987


subject: CHEBI:29987


subject: CHEBI:16015

subject_name: Glutamic acid


subject: CHEBI:16015


subject: CHEBI:16015


subject: UMLS:C0017789

subject_name: Glutamates


subject: UMLS:C0017789


subject: UMLS:C0017789


subject: CHEBI:17061

subject_name: D-Glutamine


subject: CHEBI:17061


subject: CHEBI:17061


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:29947

subject_name: glycine residue


subject: CHEBI:29947


subject: CHEBI:29947


subject: CHEBI:15428

subject_name: Glycine


subject: CHEBI:15428


subject: CHEBI:15428


subject: CHEBI:38264

subject_name: 2-amino-3-methylpentanoic acid


subject: CHEBI:38264


subject: CHEBI:38264


subject: CHEBI:43433

subject_name: L-alloisoleucine


subject: CHEBI:43433


subject: CHEBI:43433


subject: CHEBI:17191

subject_name: Isoleucine


subject: CHEBI:17191


subject: CHEBI:17191


subject: CHEBI:25017

subject_name: leucine


subject: CHEBI:25017


subject: CHEBI:25017


subject: CHEBI:16811

subject_name: Racemethionine


subject: CHEBI:16811


subject: CHEBI:16811


subject: UMLS:C0034504

subject_name: racemethionine


subject: UMLS:C0034504


subject: UMLS:C0034504


subject: CHEBI:16414

subject_name: Valine


subject: CHEBI:16414


subject: CHEBI:16414


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN

object_name: Acute appendicitis NOS (disorder)


subject: CHEBI:8232

subject_name: Piperacillin


subject: UMLS:C5908015

subject_name: Modified Interleukin-2 DF6215

object_name: Adult Solid Neoplasm


subject: UNII:04NQ160FRU

subject_name: Strontium ranelate

object_name: osteoarthritis, knee


subject: CHEBI:40050

subject_name: Amprenavir

object_name: HIV infection


subject: UMLS:C4045974

subject_name: Biosimilars

object_name: Recurrent ovarian cancer


subject: UMLS:C0796638

subject_name: Lurtotecan Liposome

object_name: Neck Carcinoma


subject: UMLS:C0796638

object_name: head and neck neoplasm


subject: UMLS:C0796638

object_name: head and neck cancer


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Adhesive Capsulitis


subject: CHEBI:2666

object_name: frozen shoulder


subject: CHEBI:2666

object_name: bursitis


subject: CHEMBL.COMPOUND:CHEMBL3544968

object_name: COPD, severe early onset


subject: CHEMBL.COMPOUND:CHEMBL3544968

object_name: chronic obstructive pulmonary disease


subject: CHEBI:70839

subject_name: Dasatinib

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:70839

object_name: Prostate cancer recurrent


subject: CHEBI:70839

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:70839

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:70839

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:70839

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:27470

subject_name: Folic acid

object_name: heart disorder


subject: CHEBI:119915

subject_name: Fentanyl

object_name: septic shock


subject: CHEBI:6121

subject_name: Ketamine


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:135537060

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:135537060

object_name: malignant pancreatic neoplasm